Literature DB >> 32544109

Effects of Dry Needling Technique Into Trigger Points of the Sternocleidomastoid Muscle in Migraine Headache: A Randomized Controlled Trial.

Tahere Rezaeian1, Zahra Mosallanezhad, Mohammad Reza Nourbakhsh, Mehdi Noroozi, Firoozeh Sajedi.   

Abstract

OBJECTIVE: The study aimed to investigate the effect of dry needling into trigger points of the sternocleidomastoid muscle in migraine headache patients.
DESIGN: Forty subjects with a migraine headache, originating from myofacial trigger points into the sternocleidomastoid muscle (20 subjects in dry needling group and 20 subjects in control group) volunteered to participate in this study. The subjects in the treatment group received three sessions of dry needling in the myofascial trigger point region. Headache frequency, headache intensity, headache duration, drug consumption, muscle thickness, pressure pain threshold, and cervical range of motion were assessed before, immediately after intervention, and at 1-mo follow-up period. In addition, this article was extracted from Iranian Register of Clinical Trials Number IRCT20171219037956N1.
RESULTS: The experimental group showed significant reduction in the headache parameters immediately after the intervention and at 1-mo follow-up, as compared with the control group. The pressure pain threshold of sternocleidomastoid muscle, cervical range of motion, and muscle thickness significantly increased in the dry needling group in comparison with the control group (P < 0.001).
CONCLUSIONS: The application of dry needling technique caused an improvement in symptoms of migraine patients. Therefore, this technique may be prescribed for treating migraine patients with myofacial trigger points in the sternocleidomastoid muscle.

Entities:  

Year:  2020        PMID: 32544109     DOI: 10.1097/PHM.0000000000001504

Source DB:  PubMed          Journal:  Am J Phys Med Rehabil        ISSN: 0894-9115            Impact factor:   2.159


  1 in total

1.  The impact of myofascial release and stretching techniques on the clinical outcomes of migraine headache: A randomized controlled trial.

Authors:  Tahere Rezaeian; Mehdi Ahmadi; Zahra Mosallanezhad; Mohammad Reza Nourbakhsh
Journal:  J Res Med Sci       Date:  2021-07-31       Impact factor: 1.852

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.